Ftse Mib
34.375,92
0,00%
DAX
18.590,89
-0,95%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
63.999,38
-1,32%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX BioPharmX Corporation (BPMX) BioPharmX Corporation (BPMX) Notizie

BPMX

BioPharmX (BPMX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX
DataOraFonteTitoloSimboloCompagnia
13/07/201715:15PR Newswire (US)BioPharmX To Present Phase 2b Clinical Trial Data at National DEF Essential Resource Meeting 2017AMEX:BPMXBioPharmX Corporation
22/06/201715:15PR Newswire (US)BioPharmX to Present Phase 2b Clinical Trial Acne Data at Alabama Dermatology Society Summer SymposiumAMEX:BPMXBioPharmX Corporation
14/06/201722:19Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BPMXBioPharmX Corporation
14/06/201715:00PR Newswire (US)BioPharmX Invited to Present at World Preclinical CongressAMEX:BPMXBioPharmX Corporation
13/06/201722:10Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
13/06/201722:05PR Newswire (US)BioPharmX Reports First Quarter 2018 Financial ResultsAMEX:BPMXBioPharmX Corporation
07/06/201712:15PR Newswire (US)BioPharmX to Report First Quarter Financial ResultsAMEX:BPMXBioPharmX Corporation
05/06/201722:10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:BPMXBioPharmX Corporation
01/06/201714:15PR Newswire (US)BioPharmX Advances BPX-01 2% Upon Achieving Statistical Significance for Primary EndpointAMEX:BPMXBioPharmX Corporation
11/05/201715:25PR Newswire (US)BioPharmX to Host "State of Acne" Symposium on June 1AMEX:BPMXBioPharmX Corporation
03/05/201722:05PR Newswire (US)BioPharmX Reports Positive Topline Results of BPX-01 Topical Minocycline for AcneAMEX:BPMXBioPharmX Corporation
02/05/201700:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
01/05/201722:39Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
28/04/201722:15PR Newswire (US)BioPharmX Announces Closing of $5.0 Million OfferingAMEX:BPMXBioPharmX Corporation
27/04/201723:20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:BPMXBioPharmX Corporation
26/04/201715:00PR Newswire (US)BioPharmX Announces $5.0 Million OfferingAMEX:BPMXBioPharmX Corporation
21/04/201722:34Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:BPMXBioPharmX Corporation
21/04/201722:24Edgar (US Regulatory)Annual Report (10-k)AMEX:BPMXBioPharmX Corporation
20/04/201715:15PR Newswire (US)BioPharmX Completes Last Subject Visit in its Phase 2b Trial of BPX-01, Expects to Report Topline Results First Half of May 2...AMEX:BPMXBioPharmX Corporation
30/03/201715:15PR Newswire (US)BioPharmX AACR Poster Will Present Findings Suggesting Molecular Iodine Inhibits Breast Cancer Cell Growth and Drives Cancer ...AMEX:BPMXBioPharmX Corporation
23/03/201721:05PR Newswire (US)BioPharmX Reports Fourth Quarter and Full Year 2017 Financial ResultsAMEX:BPMXBioPharmX Corporation
21/03/201714:15PR Newswire (US)BioPharmX Invited to Present at 27th Annual Oppenheimer Healthcare ConferenceAMEX:BPMXBioPharmX Corporation
16/03/201714:15PR Newswire (US)BioPharmX to Report Fourth Quarter and Full Year Financial ResultsAMEX:BPMXBioPharmX Corporation
13/03/201714:15PR Newswire (US)BioPharmX Society of Toxicology Poster Suggests Promise of BPX-01 as Topical Acne Therapy, Highlights SafetyAMEX:BPMXBioPharmX Corporation
09/03/201715:15PR Newswire (US)BioPharmX to Present at 29th Annual ROTH ConferenceAMEX:BPMXBioPharmX Corporation
02/03/201715:15PR Newswire (US)BioPharmX Presents Poster at American Academy of Dermatology Annual Meeting Suggesting BPX-01 Safely, Efficiently Delivers Ac...AMEX:BPMXBioPharmX Corporation
21/02/201722:18Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)AMEX:BPMXBioPharmX Corporation
13/02/201723:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BPMXBioPharmX Corporation
10/02/201723:12Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:BPMXBioPharmX Corporation
26/01/201715:15PR Newswire (US)SPIE Photonics West Presentations to Show BioPharmX was First to Visualize Minocycline on the Skin Using Multiphoton Microsco...AMEX:BPMXBioPharmX Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX

La tua Cronologia

BIT
UCG
Unicredit
BIT
ENEL
Enel
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
SPM
Saipem
BIT
SFER
Salvatore Ferragamo
BIT
LDO
Leonardo
BIT
BC
Brunello Cucinelli
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
MONC
Moncler
BIT
TEN
Tenaris
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network